Whitener Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.22M Buy
38,871
+495
+1% +$91.9K 1.91% 12
2025
Q1
$8.04M Buy
38,376
+110
+0.3% +$23K 2.28% 11
2024
Q4
$6.8M Buy
38,266
+309
+0.8% +$54.9K 1.91% 12
2024
Q3
$7.5M Sell
37,957
-163
-0.4% -$32.2K 2.13% 11
2024
Q2
$6.54M Buy
38,120
+2,766
+8% +$474K 1.98% 11
2024
Q1
$6.44M Buy
35,354
+239
+0.7% +$43.5K 2.11% 11
2023
Q4
$5.44M Buy
35,115
+344
+1% +$53.3K 1.97% 13
2023
Q3
$5.18M Buy
34,771
+820
+2% +$122K 2.08% 11
2023
Q2
$4.57M Buy
33,951
+1,101
+3% +$148K 1.75% 14
2023
Q1
$5.24M Buy
32,850
+570
+2% +$90.8K 2.19% 11
2022
Q4
$5.22M Buy
32,280
+42
+0.1% +$6.79K 2.28% 10
2022
Q3
$4.33M Buy
32,238
+3,105
+11% +$417K 2.05% 10
2022
Q2
$4.46M Buy
29,133
+1,654
+6% +$253K 2.01% 10
2022
Q1
$4.45M Buy
27,479
+1,735
+7% +$281K 1.67% 16
2021
Q4
$3.49M Buy
25,744
+2,263
+10% +$306K 1.25% 18
2021
Q3
$2.52M Sell
23,481
-1,330
-5% -$142K 1.16% 20
2021
Q2
$2.79M Buy
24,811
+1,305
+6% +$147K 1.11% 21
2021
Q1
$2.54M Buy
23,506
+25
+0.1% +$2.71K 1.1% 21
2020
Q4
$2.52M Buy
23,481
+446
+2% +$47.8K 1.15% 20
2020
Q3
$2.02M Buy
23,035
+730
+3% +$63.9K 0.97% 27
2020
Q2
$2.19M Buy
22,305
+51
+0.2% +$5.01K 1.14% 19
2020
Q1
$1.7M Buy
22,254
+190
+0.9% +$14.5K 1.1% 22
2019
Q4
$1.95M Buy
22,064
+1,494
+7% +$132K 1.01% 23
2019
Q3
$1.56M Buy
20,570
+1,590
+8% +$120K 0.85% 30
2019
Q2
$1.38M Buy
18,980
+550
+3% +$40K 0.79% 35
2019
Q1
$1.49M Buy
18,430
+1,833
+11% +$148K 0.97% 21
2018
Q4
$1.53M Buy
16,597
+1,186
+8% +$109K 1.13% 21
2018
Q3
$1.46M Buy
15,411
+1,800
+13% +$170K 0.96% 22
2018
Q2
$1.26M Buy
13,611
+1,326
+11% +$123K 0.99% 23
2018
Q1
$1.16M Buy
12,285
+3,150
+34% +$298K 0.89% 25
2017
Q4
$883K Buy
+9,135
New +$883K 0.76% 33